Results: 1-25 | 26-36
Results: 1-25/36

Authors: Caraco, Y Muszkat, M Wood, AJJ
Citation: Y. Caraco et al., Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo, PHARMACOGEN, 11(7), 2001, pp. 587-596

Authors: Xie, HG Dishy, V Sofowora, G Kim, RB Landau, R Smiley, RM Zhou, HH Wood, AJJ Harris, P Stein, CM
Citation: Hg. Xie et al., Arg(389)Gly beta(1)-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo, PHARMACOGEN, 11(3), 2001, pp. 191-197

Authors: Stein, CM Lang, CC Xie, HG Wood, AJJ
Citation: Cm. Stein et al., Hypertension in black people: study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on race, PHARMACOGEN, 11(2), 2001, pp. 95-110

Authors: Xie, HG Kim, RB Wood, AJJ Stein, CM
Citation: Hg. Xie et al., Molecular basis of ethnic differences in drug disposition and response, ANN R PHARM, 41, 2001, pp. 815-850

Authors: Xie, HG Kim, RB Stein, CM Wilkinson, GR Wood, AJJ
Citation: Hg. Xie et al., Genetic polymorphism of S-mephenytoin 4 '-hydroxylation in populations of African descent (vol 48, pg 402, 1999), BR J CL PH, 52(3), 2001, pp. 343-343

Authors: Dishy, V Sofowora, GG Xie, HG Kim, RB Byrne, DW Stein, CM Wood, AJJ
Citation: V. Dishy et al., The effect of common polymorphisms of the beta(2)-adrenergic receptor on agonist-mediated vascular desensitization, N ENG J MED, 345(14), 2001, pp. 1030-1035

Authors: Wood, AJJ
Citation: Ajj. Wood, Racial differences in the response to drugs - Pointers to genetic differences., N ENG J MED, 344(18), 2001, pp. 1393-1396

Authors: Dickmann, LJ Rettie, AE Kneller, MB Kim, RB Wood, AJJ Stein, CM Wilkinson, GR Schwarz, UI
Citation: Lj. Dickmann et al., Identification and functional characterization of a new CYP2C9 variant (CYP2C95) expressed among African Americans, MOLEC PHARM, 60(2), 2001, pp. 382-387

Authors: Dishy, V Sofowora, G Harris, PA Kandcer, M Zhan, F Wood, AJJ Stein, CM
Citation: V. Dishy et al., The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men, CLIN PHARM, 70(3), 2001, pp. 270-279

Authors: Stein, CM Sadeque, AJ Murray, JJ Wandel, C Kim, RB Wood, AJJ
Citation: Cm. Stein et al., Cyclosporine pharmacokinetics and pharmacodynamics in African American andwhite subjects, CLIN PHARM, 69(5), 2001, pp. 317-323

Authors: He, HB Sadeque, A Erve, JCL Wood, AJJ Hachey, DL
Citation: Hb. He et al., Quantitation of loperamide and N-demethyl-loperamide in human plasma usingelectrospray ionization with selected reaction ion monitoring liquid chromatography-mass spectrometry, J CHROMAT B, 744(2), 2000, pp. 323-331

Authors: Stein, CM Lang, CC Singh, I He, HB Wood, AJJ
Citation: Cm. Stein et al., Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks - Additive mechanisms leading to enhanced vascular reactivity, HYPERTENSIO, 36(6), 2000, pp. 945-951

Authors: Wandel, C Kim, RB Guengerich, FP Wood, AJJ
Citation: C. Wandel et al., Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro, DRUG META D, 28(8), 2000, pp. 895-898

Authors: Choo, EF Leake, B Wandel, C Imamura, H Wood, AJJ Wilkinson, GR Kim, RB
Citation: Ef. Choo et al., Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes, DRUG META D, 28(6), 2000, pp. 655-660

Authors: Angell, M Utiger, RD Wood, AJJ
Citation: M. Angell et al., Disclosure of authors' conflicts of interest - A follow-up. Reply, N ENG J MED, 343(2), 2000, pp. 146-147

Authors: Wood, AJJ
Citation: Ajj. Wood, Clopidogrel and thrombotic thrombocytopenic purpura. Reply, N ENG J MED, 343(16), 2000, pp. 1194-1194

Authors: Angell, M Utiger, RD Wood, AJJ
Citation: M. Angell et al., Disclosure of authors' conflicts of interest: A follow-up., N ENG J MED, 342(8), 2000, pp. 586-587

Authors: Wood, AJJ
Citation: Ajj. Wood, Thrombotic thrombocytopenic purpura and clopidogrel - A need for new approaches to drug safety., N ENG J MED, 342(24), 2000, pp. 1824-1826

Authors: Sadeque, AJM Wandel, C He, HB Shah, S Wood, AJJ
Citation: Ajm. Sadeque et al., Increased drug delivery to the brain by P-glycoprotein inhibition, CLIN PHARM, 68(3), 2000, pp. 231-237

Authors: Wandel, C Witte, JS Hall, JM Stein, CM Wood, AJJ Wilkinson, GR
Citation: C. Wandel et al., CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A41B 5 '-promoter region polymorphism, CLIN PHARM, 68(1), 2000, pp. 82

Authors: Xie, HG Stein, CM Kim, RB Gainer, JV Sofowora, G Dishy, V Brown, NJ Goree, RE Haines, JL Wood, AJJ
Citation: Hg. Xie et al., Human beta(2)-adrenergic receptor polymorphisms: No association with essential hypertension in black or white Americans, CLIN PHARM, 67(6), 2000, pp. 670-675

Authors: Kinirons, MT O'Shea, D Kim, RB Wood, AJJ Wilkinson, GR
Citation: Mt. Kinirons et al., Erythromycin breath test - Reply, CLIN PHARM, 67(5), 2000, pp. 577-578

Authors: Xie, HG Stein, CM Kim, RB Wilkinson, GR Flockhart, DA Wood, AJJ
Citation: Hg. Xie et al., Allelic, genotypic and phenotypic distributions of S-mephenytoin 4 '-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world, PHARMACOGEN, 9(5), 1999, pp. 539-549

Authors: Xie, HG Kim, RB Stein, CM Gainer, JV Brown, NJ Wood, AJJ
Citation: Hg. Xie et al., alpha(1A)-Adrenergic receptor polymorphism: association with ethnicity butnot essential hypertension, PHARMACOGEN, 9(5), 1999, pp. 651-656

Authors: Xie, HG Stein, CM Kim, RB Xiao, ZS He, N Zhou, HH Gainer, JV Brown, NJ Haines, JL Wood, AJJ
Citation: Hg. Xie et al., Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals, PHARMACOGEN, 9(4), 1999, pp. 511-516
Risultati: 1-25 | 26-36